BioXcel Therapeutics, Inc.

BioXcel Therapeutics is a biopharmaceutical company committed to developing innovative medicines in neuroscience and immuno-oncology. Their approach leverages artificial intelligence to accelerate drug discovery and development, aiming to address unmet medical needs with a focus on improving patients' lives. They utilize their proprietary AI platform, NovareAI, to analyze large datasets and identify new therapeutic indications for existing approved drugs and clinically evaluated product candidates. This re-innovation strategy helps reduce development costs and timelines while aiming for higher success rates in bringing new treatments to market.

BioXcel Therapeutics' current product pipeline includes several promising candidates in both neuroscience and immuno-oncology. Their first commercial product, IGALMI (dexmedetomidine) sublingual film, is FDA-approved for the acute treatment of agitation associated with schizophrenia or bipolar disorder in adults. The company continues to invest in research and development, with a focus on advancing treatments for agitation associated with dementia, apathy in dementia, and aggressive forms of prostate cancer.

The company's website states they are looking for highly motivated employees, but provides no information about the flexibility of the available roles.

BioXcel Therapeutics is a biopharmaceutical company committed to developing transformative medicines in neuroscience and immuno-oncology using artificial intelligence (AI). Their unique AI platform, NovareAI, is designed to expedite drug discovery and development, reduce costs, and increase the probability of success by leveraging existing approved drugs and clinically evaluated product candidates. They are focused on addressing diseases with significant unmet medical needs and large market opportunities, ultimately aiming to improve the lives of patients through innovative and cutting-edge research.

BioXcel Therapeutics fosters a culture of innovation and collaboration, encouraging employees to push boundaries and utilize cutting-edge technology in drug discovery and development. The company values creativity, enthusiasm, and a passion for research, seeking highly motivated individuals who are eager to contribute to breakthrough therapies that transform patients' lives.